Idiopathic Cutaneous Pseudolymphoma Treated Successfully with Hydroxychloroquine: A Case Report and Literature Review


  • Hayato Mizuno Hiroshima University
  • Shunsuke Takahagi Department of Dermatology, Institute of Biomedical & Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, Hiroshima 734-8551, Japan
  • Satoko Morita Hiroshima University
  • Akiko Kamegashira Hiroshima University
  • Akio Tanaka Hiroshima University



cutaneous pseudolymphoma, hydroxychloroquine, corticosteroid


Abstract is missing (Short Communication)


Download data is not yet available.


Miguel D, Peckruhn M, Elsner P. Treatment of cutaneous pseudolymphoma: a systematic review. Acta Derm Venereol 2018; 98: 310-317. DOI:

Stoll DM. Treatment of cutaneous pseudolymphoma with hydroxychloroquine. J Am Acad Dermatol 1983; 8: 696-699. DOI:

Dragonetti E, Cianchini G, Mastrangelo L, Mellone P, Baldi A. Cutaneus pseudolymphoma: a case report. In Vivo 2004; 18: 549-551.

Moulonguet I, Ghnassia M, Molina T, Fraitag S. Miliarial-type perifollicular B-cell pseudolymphoma (lymphocytoma cutis): a misleading eruption in two women. J Cutan Pathol 2012; 39: 1016-1021. DOI:

Ye CH, Chen CJ, Chang KC, Wu YH, Chen ML, Chiu TM. Cutaneous pseudolymphoma with Langerhans cell hyperplasia - a rare case with clinical presentation mimicking malignancy and potential diagnostic pitfall. Am J Dermatopathol 2021; 43: e280-e284. DOI:

Joshi TP, Duvic M, Torres-Cabala CA, Tschen J. Treatment with dupilumab for refractory cutaneous B-cell pseudolymphoma. JAMA Dermatol 2022; 158: 697-699. DOI:

Sardana K, Sinha S, Sachdeva S. Hydroxychloroquine in dermatology and beyond: recent update. Indian Dermatol Online J 2020; 11: 453-464. DOI:

Kutzner H, Kerl H, Pfaltz MC, Kempf W. CD123-positive plasmacytoid dendritic cells in primary cutaneous marginal zone B-cell lymphoma: diagnostic and pathogenetic implications. Am J Surg Pathol 2009; 33: 1307-1313. DOI:

Müller-Calleja N, Manukyan D, Canisius A, Strand D, Lackner KJ. Hydroxychloroquine inhibits proinflammatory signalling pathways by targeting endosomal NADPH oxidase. Ann Rheum Dis 2017; 76: 891-897. DOI:



How to Cite

Mizuno, H., Takahagi, S., Morita, S., Kamegashira, A., & Tanaka, A. (2022). Idiopathic Cutaneous Pseudolymphoma Treated Successfully with Hydroxychloroquine: A Case Report and Literature Review. Acta Dermato-Venereologica, 102, adv00798.



Short Communication